BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

Status unconfirmed

Conditions studied: Diabetes Mellitus, Type 2

In brief

An observational study of electronic patient data to compare diabetes medications and to determine which ones offer the best balance of risks and benefits.

Key facts

Study ID

NCT05161429

Run by

Brigham and Women's Hospital

People needed

550000

Starts

2021-07-01

Expected to finish

2024-06-30

Last updated by the study team

2023-06-22

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• HealthCore, Inc. — Wilmington, Delaware, United States (enrolling)
• Humana — Lexington, Kentucky, United States (enrolling)
• Brigham and Women's Hospital — Boston, Massachusetts, United States (enrolling)
• Greater Plains Collaborative — Beachwood, Ohio, United States (enrolling)
• Baylor Scott & White — Dallas, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.